Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effects of IGF-I in HIV Metabolic Disease

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Roy Kim, University of Texas Southwestern Medical Center
ClinicalTrials.gov Identifier:
NCT01329744
First received: April 4, 2011
Last updated: May 23, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: June 2013
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)